Vincent Mascitti
11Patents
6h-index
5Co-inventors
55Inventor score
Filing activity: Aug 24, 2009 → Jun 24, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8080580B2 | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | Human Necessities | 21 | Active |
| US9617293B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 11 | Active |
| US9340553B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 11 | Active |
| US10039778B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 8 | Active |
| US10813942B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 7 | Active |
| US10376531B2 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | Emerging Cross-Sectional Technologies | 7 | Active |
| US8669380B2 | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | Chemistry; Metallurgy | 2 | Active |
| US10851367B2 | Tissue-specific genome engineering using CRISPR-Cas9 | Chemistry; Metallurgy | 1 | Active |
| US9308204B2 | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | Chemistry; Metallurgy | 0 | Active |
| US9439902B2 | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | Chemistry; Metallurgy | 0 | Active |
| US9439901B2 | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.